Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMED
2326
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.86M | ﹤0.01% |
411,600
+42,004
| +11% | +$170K |
|
2327
Franklin Covey
FC
$225M
| $1.86M | ﹤0.01% |
91,573
-15,627
| -15% | -$291K |
|
2328
FS Bancorp
FSBW
$323M
| $1.86M | ﹤0.01% |
72,000
+48,800
| +210% | +$1.15M |
|
2329
PDS Biotechnology
PDSB
$13M
| $1.85M | ﹤0.01% |
8,635
+5,595
| +184% | +$1.16M |
|
|
JAX
2330
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $1.85M | ﹤0.01% |
159,400
+57,800
| +57% | +$597K |
|
2331
LSI Industries
LYTS
$907M
| $1.83M | ﹤0.01% |
276,500
+10,600
| +4% | +$74.1K |
|
2332
Ameresco
AMRC
$1.51B
| $1.82M | ﹤0.01% |
233,900
+26,300
| +13% | +$186K |
|
2333
Sanmina
SANM
$11.2B
| $1.82M | ﹤0.01% |
48,933
-258,000
| -84% | -$9.63M |
|
|
RADA
2334
DELISTED
Rada Electronic Industries Ltd
RADA
| $1.81M | ﹤0.01% |
531,900
+502,392
| +1,703% | +$1.27M |
|
|
PKD
2335
DELISTED
Parker Drilling Company
PKD
| $1.81M | ﹤0.01% |
109,627
+820
| +0.8% | +$15K |
|
2336
Arq
ARQ
$101M
| $1.81M | ﹤0.01% |
164,800
-8,200
| -5% | -$82.4K |
|
|
ADAM
2337
Adamas Trust
ADAM
$912M
| $1.8M | ﹤0.01% |
73,125
+53,080
| +265% | +$1.33M |
|
2338
Identive
INVE
$62.4M
| $1.8M | ﹤0.01% |
387,239
+9,191
| +2% | +$46.1K |
|
2339
Harte-Hanks
HHS
$31.5M
| $1.79M | ﹤0.01% |
167,400
+7,150
| +4% | +$65.8K |
|
|
MRNS
2340
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.78M | ﹤0.01% |
+75,944
| New | +$851K |
|
2341
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $1.78M | ﹤0.01% |
15,900
+11,533
| +264% | +$1.28M |
|
2342
Lincoln Educational Services
LINC
$924M
| $1.77M | ﹤0.01% |
709,287
-29,813
| -4% | -$88.2K |
|
|
XCRA
2343
DELISTED
Xcerra Corporation
XCRA
| $1.77M | ﹤0.01% |
180,000
-410,500
| -70% | -$3.97M |
|
|
SNC
2344
DELISTED
State National Companies, Inc.
SNC
| $1.77M | ﹤0.01% |
84,200
-299,100
| -78% | -$6.06M |
|
2345
EyePoint Inc
EYPT
$1.21B
| $1.76M | ﹤0.01% |
146,410
+9,610
| +7% | +$123K |
|
|
OAKS
2346
DELISTED
Five Oaks Investment Corp.
OAKS
| $1.75M | ﹤0.01% |
392,609
-33,500
| -8% | -$151K |
|
2347
Insmed
INSM
$26.9B
| $1.74M | ﹤0.01% |
+55,887
| New | +$1.06M |
|
|
SBR
2348
Sabine Royalty Trust
SBR
$1.07B
| $1.74M | ﹤0.01% |
42,641
-2,450
| -5% | -$96.7K |
|
|
ZAGG
2349
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.74M | ﹤0.01% |
110,500
-67,700
| -38% | -$743K |
|
2350
3D Systems Corp
DDD
$618M
| $1.74M | ﹤0.01% |
129,750
-123,100
| -49% | -$1.8M |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.